Lindus Health and Thirty Madison complete enrolment for telemedicine trial

Lindus Health and Thirty Madison have successfully completed the enrolment for a clinical trial evaluating the effectiveness of Thirty Madison’s personalized dermatology telemedicine platform, Facet. This innovative telehealth platform provides evidence-based consultations, patient-reported monitoring, and messaging for patients with skin conditions such as atopic dermatitis. The trial, remotely managed by Lindus Health, aims to assess the platform’s ability to expand treatment access for eczema patients. The completion of the trial’s enrolment is a significant step, especially in light of a recent study showing strong patient interest in participating in clinical trials for skin conditions. This achievement underscores the potential of telemedicine platforms to enhance the healthcare landscape and improve patient care.